These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

711 related items for PubMed ID: 16709383

  • 1. [Effect of combined beta-blocker and angiotensin-converting enzyme inhibitor treatment on 1-year survival after acute myocardial infarction: findings of the PRIAMHO-II registry].
    Arós F, Loma-Osorio A, Vila J, López-Bescós L, Cuñat J, Rodríguez E, San José JM, Heras M, Marrugat J, Investigadores del PRIAMHO II.
    Rev Esp Cardiol; 2006 Apr; 59(4):313-20. PubMed ID: 16709383
    [Abstract] [Full Text] [Related]

  • 2. Usefulness of beta blockers in high-risk patients after myocardial infarction in conjunction with captopril and/or valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] trial).
    Califf RM, Lokhnygina Y, Velazquez EJ, McMurray JJ, Leimberger JD, Lewis EF, Diaz R, Murin J, Pfeffer MA.
    Am J Cardiol; 2009 Jul 15; 104(2):151-7. PubMed ID: 19576338
    [Abstract] [Full Text] [Related]

  • 3. The management of patients who have suffered an acute myocardial infarction in a tertiary care centre.
    Haddad H, Searles G, Gillis A.
    Can J Cardiol; 2001 Feb 15; 17(2):179-83. PubMed ID: 11223488
    [Abstract] [Full Text] [Related]

  • 4. [Reduction in acute myocardial infarction mortality over a five-year period].
    Heras M, Marrugat J, Arós F, Bosch X, Enero J, Suárez MA, Pabón P, Ancillo P, Loma-Osorio A, Rodríguez JJ, Subirana I, Vila J, en representación de los investigadores del estudio PRIAMHO.
    Rev Esp Cardiol; 2006 Mar 15; 59(3):200-8. PubMed ID: 16712743
    [Abstract] [Full Text] [Related]

  • 5. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
    Wienbergen H, Zeymer U, Gitt AK, Juenger C, Schiele R, Heer T, Towae F, Senges J, MITRA PLUS Study Group.
    Am J Cardiol; 2007 May 01; 99(9):1208-11. PubMed ID: 17478143
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of medical therapy for the reduction of heart failure events in patients with implanted cardioverter defibrillators.
    Pietrasik G, Goldenberg I, McNitt S, Polonsky B, Moss AJ, Zareba W.
    J Cardiovasc Electrophysiol; 2009 Apr 01; 20(4):395-400. PubMed ID: 19017351
    [Abstract] [Full Text] [Related]

  • 7. Suboptimal use of evidence-based medical therapy in patients with acute myocardial infarction from the Korea Acute Myocardial Infarction Registry: prescription rate, predictors, and prognostic value.
    Lee JH, Yang DH, Park HS, Cho Y, Jeong MH, Kim YJ, Kim KS, Hur SH, Seong IW, Hong TJ, Cho MC, Kim CJ, Jun JE, Park WH, Chae SC, Korea Acute Myocardial Infarction Registry Investigators.
    Am Heart J; 2010 Jun 01; 159(6):1012-9. PubMed ID: 20569714
    [Abstract] [Full Text] [Related]

  • 8. Poor short-term survival and low use of cardiovascular medications in elderly dialysis patients after acute myocardial infarction.
    Winkelmayer WC, Charytan DM, Levin R, Avorn J.
    Am J Kidney Dis; 2006 Feb 01; 47(2):301-8. PubMed ID: 16431259
    [Abstract] [Full Text] [Related]

  • 9. Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry.
    Danchin N, Cambou JP, Hanania G, Kadri Z, Genès N, Lablanche JM, Blanchard D, Vaur L, Clerson P, Guéret P, USIC 2000 investigators.
    Am Heart J; 2005 Dec 01; 150(6):1147-53. PubMed ID: 16338251
    [Abstract] [Full Text] [Related]

  • 10. Effects of a secondary prevention combination therapy with an aspirin, an ACE inhibitor and a statin on 1-year mortality of patients with acute myocardial infarction treated with a beta-blocker. Support for a polypill approach.
    Zeymer U, Jünger C, Zahn R, Bauer T, Bestehorn K, Senges J, Gitt A.
    Curr Med Res Opin; 2011 Aug 01; 27(8):1563-70. PubMed ID: 21682553
    [Abstract] [Full Text] [Related]

  • 11. [ACE inhibitors and angiotensin II receptor antagonists in acute coronary syndrome].
    Milicić D.
    Acta Med Croatica; 2004 Aug 01; 58(2):129-34. PubMed ID: 15208798
    [Abstract] [Full Text] [Related]

  • 12. Angiotensin-converting enzyme inhibitors post-myocardial infarction.
    Young JB.
    Cardiol Clin; 1995 Aug 01; 13(3):379-90. PubMed ID: 7585774
    [Abstract] [Full Text] [Related]

  • 13. AT1 receptor blockade for the prevention of cardiovascular events after myocardial infarction.
    Azadpour M, Lamas GA.
    Expert Rev Cardiovasc Ther; 2004 Nov 01; 2(6):891-902. PubMed ID: 15500434
    [Abstract] [Full Text] [Related]

  • 14. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ, Muhlestein JB, Bair TL, Renlund DG, Lappé DL, Jensen KR, Horne BD, Carter MA, Anderson JL, Intermountain Heart Collaborative Study Group.
    Am J Cardiol; 2005 Apr 01; 95(7):827-31. PubMed ID: 15781009
    [Abstract] [Full Text] [Related]

  • 15. Dual renin angiotensin system blockade in patients with acute myocardial infarction and preserved left ventricular systolic function.
    Suşan M, Petrescu L, Riviş AI, Suşan RM, Burghină D, Dan R, Cozma D, Drăgulescu SI.
    Rom J Intern Med; 2005 Apr 01; 43(3-4):187-98. PubMed ID: 16812979
    [Abstract] [Full Text] [Related]

  • 16. Effect of Angiotensin-converting enzyme inhibition on one-year mortality and frequency of repeat acute myocardial infarction in patients with acute myocardial infarction.
    Milonas C, Jernberg T, Lindbäck J, Agewall S, Wallentin L, Stenestrand U, RIKS-HIA Group.
    Am J Cardiol; 2010 May 01; 105(9):1229-34. PubMed ID: 20403471
    [Abstract] [Full Text] [Related]

  • 17. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker).
    Dimopoulos K, Salukhe TV, Coats AJ, Mayet J, Piepoli M, Francis DP.
    Int J Cardiol; 2004 Feb 01; 93(2-3):105-11. PubMed ID: 14975535
    [Abstract] [Full Text] [Related]

  • 18. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB, Peterson ED, PREVENT IV Investigators.
    Ann Thorac Surg; 2007 Mar 01; 83(3):993-1001. PubMed ID: 17307447
    [Abstract] [Full Text] [Related]

  • 19. Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome.
    Yan AT, Yan RT, Tan M, Huynh T, Soghrati K, Brunner LJ, DeYoung P, Fitchett DH, Langer A, Goodman SG, Canadian ACS Registries Investigators.
    Am Heart J; 2007 Dec 01; 154(6):1108-15. PubMed ID: 18035083
    [Abstract] [Full Text] [Related]

  • 20. Effect of statins, angiotensin-converting enzyme inhibitors, and beta blockers on survival in patients >or=65 years of age with heart failure and preserved left ventricular systolic function.
    Shah R, Wang Y, Foody JM.
    Am J Cardiol; 2008 Jan 15; 101(2):217-22. PubMed ID: 18178410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.